CAS: 594-16-1; 2,2-Dibromopropane

该化合物是一种卤化有机化合物,其特点是与丙烷主干骨中央碳相连的两个溴原子,这种结构具有高度的回活动性,使其成为有机合成中有价值的中间体,特别是用于核生殖器替代和消化反应.在受控条件下,这种结构的稳定性允许精确地用于烷基和红斑试剂形成.该化合物的高密度和低溶解性促进了其在净化过程中的分离. 2,2-二溴丙烷通常用于制药和农用化学研究,其可预测的回活动及其与各种催化剂的兼容性提高了合成效率.由于它的潜在毒性和易燃性,适当的处理是必不可少的.

结构式图片

欧盟法规

REACH注册ECHA物质C&L通报REACH预注册

上下游产品

CAS号557-93-7 2-溴丙烯 | CAS号74-99-7 丙炔 | CAS号7462-74-0 2-溴异丁酰胺 | CAS号75-26-3 2-溴丙烷 | CAS号7740-07-0 2,2-dimethyl-1,... | CAS号108-24-7 乙酸酐 | CAS号74-98-6 丙烷 | CAS号67-64-1 丙酮 | CAS号78-75-1 1,2-二溴丙烷 | CAS号10035-10-6 氢溴酸 | CAS号2310-98-7 2-氯-2-溴丙烷 | CAS号19781-52-3 2,3-二甲基-4-戊烯-2-醇 | CAS号547-63-7 异丁酸甲酯 | CAS号29195-13-9 3-heptyl-2,2-di... | CAS号2875-95-8 丙烷-2,2-d2 | CAS号78-75-1 1,2-二溴丙烷 | CAS号75-26-3 2-溴丙烷 | CAS号557-93-7 2-溴丙烯 | CAS号10035-10-6 氢溴酸

合成工艺路线路线简述

    2-溴丙烯置于氢溴酸,三氯化铁体系中,化学反应生成 2,2-二溴丙烷
    参考文献:Kharasch; Kleiger; Mayo,Journal Of Organic Chemistry,1939,Vol. 4,P. 431,434
    标题:Kharasch; Kleiger; Mayo,Journal Of Organic Chemistry,1939,Vol. 4,P. 431,434

    海关参考信息

    专利信息


    专利号:WO-0206209-A1
    优先权日:2000-07-19
    标 题 :Synthesis method for n1,n3-bis (2.aminoethyl) propane-1,3-diamine, synthesis intermediates, resulting products and use thereof in synthesis of cyclam
    发明人:HANDEL HENRI; BERNARD HELENE; ANTOINE MARINE
    权利人:UNIV BRETAGNE OCCIDENTALE; HANDEL HENRI; BERNARD HELENE; ANTOINE MARINE
    摘要:The invention concerns a method of synthesis of a linear polynitrogen-containing derivative, namely N1,N3-bis (2-aminoethyl) propane-1,3-diamine of general formula (I) using as synthesis intermediates compounds (II) and (III). The invention also concerns the resulting products and their use in the synthesis of cyclic polynitrogen-containing derivatives such as cyclam.

    专利号:US-4111933-A
    优先权日:1976-04-30
    标题:Protection of functional groups during reaction and their subsequent restoration
    发明人:ECKERT HEINER; UGI IVAR; KABBE HANS-JOACHIM
    权利人:BAYER AG
    摘要:In the process for preparing an organic compound of the formula n n A' -- X n n in which n X is an amino group, a hydroxyl group or a carboxyl group, and n A' is the remainder of the molecule, from an organic compound of the formula n n A -- X n n in which n A is the remainder of the molecule which can undergo reaction to form A', by converting A -- X into a compound of the formula n n A -- Z -- COOR n n in which n Z is --NH--, --O-- or a direct C--C bond, and n R is a radical of the formula ##STR1## IN WHICH Y is a direct C--C single bond, the --CHâ•?CH-- group or an arylene group, n R 1 to R 4 each independently is hydrogen, halogen or an alkyl, aryl, aralkyl, alkoxycarbonyl, alkylaminocarbonyl, arylaminocarbonyl or cycloalkylaminocarbonyl radical, or n R 1 + r 2 and R 3 + R 4 each independently completes a 5- or 6-membered carbocyclic ring, or n R 1 and R 3 conjointly with the grouping --C--Y--C-- forms a carbocyclic ring with 5 or 6 carbon atoms, and Hal is halogen, n Thereby to protect X, then converting A -- Z -- COOR into a compound of the formula n n A' -- Z -- COOR n n and then treating the compound A' -- Z -- COOR to restore the group X, the improvement which comprises effecting the treatment of the compound A' -- Z -- COOR with an alkali metal compound of a complex of monovalent cobalt. The process is applicable particularly to aminocarboxylic acids including intermediates from various stages of the synthesis of penicillins and cephalosporis.

    专利号:WO-2023151188-A1
    优先权日:2022-02-08
    标题 :Green synthesis method of antiviral drug intermediate
    发明人:XIA BIN; WANG JIAMING; ZHANG XIANSHU; CAI LINGLI; WANG ZIKUN; CAO MING; YANG SHAOBO; GAO QIANG; ZHENG BAOFU
    权利人:SHANGHAI HAOYUAN CHEMEXPRESS CO LTD
    摘要:The present application provides a green synthesis method of an antiviral drug intermediate. The method comprises: in the presence of a catalyst, adding zinc powder into a compound as represented by a formula II and performing a cyclization reaction with dihaloalkane to generate a compound as represented by a formula I, zinc halide being not required to be added to the cyclization reaction, wherein R1 is selected from H or an amino-protecting group, and R2 is selected from substituted or unsubstituted C1-C10 alkyl, substituted or unsubstituted C6-C14 aryl or substituted or unsubstituted C7-C14 aralkyl; R3 and R4 are each independently selected from hydrogen, substituted or unsubstituted C1-C10 alkyl, and R3 and R4 can be connected to form a fatty ring containing 3-10 carbon atoms. The synthesis method is short in steps, dangerous and expensive materials are not used, a reaction conversion rate is high, reaction time is short, and operation is easy and convenient. Production costs and post-treatment costs are reduced, and a cost advantage is obvious. The method can be widely used for preparing antiviral drugs of nirmatrelvir, boceprevir or narlaprevir, and has good market prospects.

    专利号:US-6232318-B1
    优先权日:1998-11-12
    标 题:Pyrimidinedione derivatives useful as alpha 1A adrenoceptor antagonists
    发明人:NERENBERG JENNIE B; BOCK MARK G
    权利人:MERCK & CO LTD
    摘要:Novel pyrimidinedione compounds and pharmaceutically acceptable salts thereof are disclosed. The synthesis of these compounds and their use as alpha 1a adrenergic receptor antagonists is also described. One application of these compounds is in the treatment of benign prostatic hyperplasia. These compounds are selective in their ability to relax smooth muscle tissue enriched in the alpha 1a receptor subtype without at the same time inducing hypotension. One such tissue is found surrounding the urethral lining. Therefore, one utility of the instant compounds is to provide acute relief to males suffering from benign prostatic hyperplasia, by permitting less hindered urine flow. Another utility of the instant compounds is provided by combination with a human 5-alpha reductase inhibitory compound, such that both acute and chronic relief from the effects of benign prostatic hyperplasia can be achieved.

    专利号:WO-2024131056-A1
    优先权日:2022-12-20
    标 题:Synthesis method for intermediate of paxlovid and of boceprevir
    发明人:YANG XIAOLONG; PEI PIBING; CHEN QIAN; YANG TIEBO; Yang Kaimike
    权利人:HUANGGANG LUBAN PHARMACEUTICAL CO LTD
    摘要:Disclosed in the present invention is a novel method for synthesizing a compound represented by formula 1. The method comprises: reacting diphenyl sulfide with 2-bromopropane to obtain a compound represented by formula 5; reacting a compound represented by formula 4 with the compound represented by formula 5 to obtain a compound represented by formula 6; and subjecting the compound represented by formula 6 to deprotection and salt forming under the effect of hydrogen chloride, so as to obtain the compound represented by formula 1. The method of the present invention can be carried out under mild conditions, thereby facilitating industrial production and further improving the reaction yield.

    专利号:JP-2007521235-A
    优先权日:2003-08-19
    标题 :Method and apparatus for the synthesis of olefins, alcohols, ethers and aldehydes
    杭州氟药药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.fluoropharm.cn
    企业联系电话:0571-85586753;13336034509(微信同号)👤
    📞杭州氟药药业有限公司 ⚠️参考联系方式
    联系人:张经理
    电话:0571-85586753;13336034509(微信同号)
    手机:13336034509
    传真:询价请加QQ 2818889690 或发邮件
    邮箱:sales@fluoropharm.com
    通信地址: 浙江省杭州市滨江区西兴街道江陵路88号
    邮编: 310053
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:浙江省杭州市滨江区西兴街道江陵路88号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    天津民祥药业有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.mxpharm.com
    企业联系电话:022-59596766;18222332696;13313219033👤
    📞天津民祥药业有限公司 ⚠️参考联系方式
    联系人:国经理
    电话:022-59596766;18222332696;13313219033
    手机:18222332696
    传真:86-22-88718329
    邮箱:qiaojw@mxpharm.com
    通信地址: 天津市静海区泰安道17号
    邮编: 300350
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:天津市静海区泰安道17号
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    上海西加生物科技有限公司
    ⚠️ 未注册 · 未认证企业
    ⚠️ 该商家尚未完成注册及企业认证,请用户仔细辨别,谨慎交易。
    数据来源于公开网络搜索,平台未作核实,请自行辨别。
    🏢敬请 企业认领
    🏬开设公司展台
    📢获取免费会员权益
    🎖️点亮专属注册企业标签
    📇展现公司完整信息 样本查看立即注册认领 →
    网址: http://www.sigachem.com
    企业联系电话:18901978308👤
    📞上海西加生物科技有限公司 ⚠️参考联系方式
    联系人:龚经理
    电话:18901978308
    手机:13764598896

    邮箱:grace8018@163.com
    通信地址: 上海市崇明区新河镇新申路921弄2号W区175室
    邮编:
    🆔 联系时候可告知是从"百琢研"平台获取的信息.
    ⚠️ 声明: 该企业未认证、未认领,请自行辨别信息的真实性和可靠性。咨询或交易时请注意风险评估与信息核实,百琢研不参与任何交易。企业认领注册入口→

    地址:上海市崇明区新河镇新申路921弄2号W区175室
    ⚠️ 未注册 · 未认证企业
    注册入口 备注: 📌 数据来源说明:本展台内容基于各搜索引擎等公开数据整理,仅作展示用途。请用户自行辨别
    ✉️ 若企业需抹除展台内容或有异议, 请通过页面底部联系方式告知我们,我们会尽快处理。
    第 1 / 1 页

    供应商参考报价(招募中)

    品牌试剂参考报价(招募中)

    📌 第三方产品分析报告

    ✅ COA系统入驻 | 共享模式

    合成参考文献


    摘要:Petasis, N. A., Science of Synthesis, (2010) 47, 232.
    摘要:Inoue, S.; Driess, M., Science of Synthesis Knowledge Updates, (2012) 4, 234.
    📝 需求与反馈
    尽可能描述清楚需求与问题信息
    ×

    通知